文献速递妇科

平等医疗体系下子宫内膜癌生存的种族差异

Racial disparities in survival among women with endometrial cancer in an equal access system.
PubMed 文献 · Gynecol Oncol · 2021-07-27

研究基于美国国防部自动中央肿瘤登记库,纳入1988至2013年间经手术治疗的144例非西班牙裔黑人和1439例非西班牙裔白人子宫内膜癌患者,比较其总生存。在提供平等医疗的军事卫生系统中,黑人女性生存仍显著差于白人女性(HR=1.64,95%CI=1.19-2.27),提示就医可及性之外的因素参与种族差异。

要点

  • 平等医疗准入下,黑人子宫内膜癌患者总生存仍显著差于白人(HR=1.64)。
  • 生存差异在校正年龄、分期、组织学/分级和辅助治疗后仍存在。
  • 差异主要见于低危特征(I/II期或低级别)或未接受辅助治疗者。

核心结论

  • 在提供平等医疗的军事卫生系统中,非西班牙裔黑人子宫内膜癌患者的总生存仍显著差于非西班牙裔白人女性,提示就医可及性之外的因素可能与种族差异相关。

研究设计与样本

  • 基于美国国防部自动中央肿瘤登记库的回顾性队列研究,纳入1988至2013年间组织学确诊并接受手术治疗的144例非西班牙裔黑人和1439例非西班牙裔白人子宫内膜癌患者。

主要发现

  • Kaplan-Meier曲线显示非西班牙裔黑人女性生存差于非西班牙裔白人女性(log-rank P < 0.0001)。
  • 校正年龄、诊断时期、肿瘤分期、肿瘤组织学/分级和辅助治疗后,生存差异仍存在(HR = 1.64,95% CI = 1.19 to 2.27)。
  • 按肿瘤特征或治疗分层的多变量分析显示,种族差异仅限于低危特征(I/II期疾病或低级别子宫内膜癌)或未接受辅助治疗女性。

临床怎么用

  • 在平等医疗体系中,对黑人子宫内膜癌患者仍应关注生存差异,尤其低危特征或未接受辅助治疗者。
  • 临床决策不能仅依赖医疗可及性平等,需探索其他导致差异的因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The mortality rate for Black women with endometrial cancer (EC) is double that of White women, although the incidence rate is lower among Black women. Unequal access to care may contribute to this racial disparity. This study aimed to assess whether survival varied between non-Hispanic Black (NHB) and non-Hispanic White (NHW) women with EC in the Military Health System (MHS) which provides equal access care to its beneficiaries despite racial/ethnic background. METHODS: The study was conducted using data from the U.S. Department of Defense's (DoD) Automated Central Tumor Registry (ACTUR). Study subjects included NHB and NHW women with histologically confirmed and surgically managed EC diagnosed between 1988 and 2013. The study outcome was all-cause death. Overall survival between NHB and NHW women was compared using multivariable Cox modeling. RESULTS: The study included 144 NHB and 1439 NHW women with EC. Kaplan-Meier curves showed NHB women had worse survival than NHW women (log-rank P < 0.0001). The disparity in survival between NHB and NHW women persisted after adjusting for age, diagnosis period, tumor stage, tumor histology/grade, and adjuvant treatment (HR = 1.64, 95% CI = 1.19 to 2.27). Multivariable analyses stratified by tumor features or treatment showed that the racial disparity was confined to women with low-risk features (stage I/II disease or low-grade EC) or no adjuvant treatment. CONCLUSION: There were racial differences in overall survival between NHB and NHW women with EC in the MHS equal access healthcare system, suggesting that factors other than access to care may be related to this racial disparity.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Park AB, Darcy KM, Tian C, et al. Racial disparities in survival among women with endometrial cancer in an equal access system. Gynecol Oncol. 2021. PMID: 34325938. doi:10.1016/j.ygyno.2021.07.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。